Anavex Life Sciences Corp. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 6.55 M | $70.37 M | -2.80% | 7.73% |
VANGUARD GROUP INC | 02/11/2025 | 4.68 M | $50.27 M | -1.26% | 5.61% |
STATE STREET CORP | 02/14/2025 | 2.41 M | $25.90 M | -21.33% | 2.89% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.87 M | $20.14 M | -0.44% | 2.21% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.13 M | $12.19 M | 375.95% | 1.36% |
MORGAN STANLEY | 02/14/2025 | 904,159 | $9.71 M | 25.83% | 1.08% |
NWAM LLC | 02/05/2025 | 913,051 | $9.81 M | 0.28% | 1.08% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 776,901 | $8.34 M | -6.47% | 0.93% |
NORTHERN TRUST CORP | 02/14/2025 | 706,901 | $7.59 M | 1.57% | 0.85% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 677,215 | $7.27 M | 1.69% | 0.80% |
INVESCO LTD. | 02/13/2025 | 615,048 | $6.61 M | 2,419.76% | 0.74% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 538,541 | $5.78 M | -18.66% | 0.65% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 490,600 | $5.27 M | -0.59% | 0.59% |
PIER CAPITAL, LLC | 02/11/2025 | 441,915 | $4.75 M | 100.00% | 0.52% |
UBS GROUP AG | 02/14/2025 | 418,764 | $4.50 M | 221.99% | 0.50% |
ESSENTIAL PLANNING, LLC. | 02/10/2025 | 413,088 | $3.25 M | 100.00% | 0.49% |
CITADEL ADVISORS LLC | 02/14/2025 | 372,500 | $4.00 M | 39.57% | 0.45% |
SCULPTOR CAPITAL LP | 02/14/2025 | 371,400 | $3.99 M | 0.00% | 0.45% |
SCULPTOR CAPITAL LP | 02/14/2025 | 370,100 | $3.97 M | -0.08% | 0.44% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 277,900 | $2.98 M | 47.35% | 0.33% |
CITADEL ADVISORS LLC | 02/14/2025 | 240,906 | $2.59 M | 843.80% | 0.29% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 220,249 | $2.37 M | -2.10% | 0.26% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 213,600 | $2.29 M | 10.22% | 0.26% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 213,200 | $2.29 M | -12.55% | 0.26% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 207,778 | $2.23 M | -39.07% | 0.25% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 198,780 | $2.13 M | -27.79% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 178,965 | $1.92 M | 0.00% | 0.21% |
WOLVERINE TRADING, LLC | 02/14/2025 | 157,700 | $1.74 M | 399.05% | 0.19% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 158,674 | $1.70 M | 100.00% | 0.19% |
HEARTLAND ADVISORS INC | 02/12/2025 | 155,850 | $1.67 M | 100.00% | 0.18% |
JUMP FINANCIAL, LLC | 02/13/2025 | 153,231 | $1.65 M | 100.00% | 0.18% |
BARCLAYS PLC | 02/13/2025 | 148,803 | $1.60 M | -4.11% | 0.18% |
MARSHALL WACE, LLP | 02/13/2025 | 141,119 | $1.52 M | 100.00% | 0.17% |
RHUMBLINE ADVISERS | 01/30/2025 | 123,699 | $1.33 M | 2.91% | 0.15% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 115,200 | $1.24 M | 6.82% | 0.14% |
D. E. SHAW & CO., INC. | 02/14/2025 | 105,130 | $1.13 M | 100.00% | 0.13% |
JANE STREET GROUP, LLC | 02/14/2025 | 104,697 | $1.12 M | 67.74% | 0.13% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 101,473 | $1.09 M | -22.42% | 0.12% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 102,662 | $1.10 M | 7.64% | 0.12% |
CITIGROUP INC | 02/12/2025 | 93,477 | $1.00 M | 53.75% | 0.11% |
VIRTU FINANCIAL LLC | 02/11/2025 | 90,034 | $967,000 | 100.00% | 0.11% |
HIKARI POWER LTD | 02/04/2025 | 85,585 | $919,000 | 0.00% | 0.10% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 83,347 | $895,000 | 311.12% | 0.10% |
PVG ASSET MANAGEMENT CORP | 02/21/2025 | 78,490 | $842,982 | 503.54% | 0.09% |
CARNEGIE CAPITAL ASSET MANAGEMENT, LLC | 01/15/2025 | 76,778 | $824,596 | 4.70% | 0.09% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 74,601 | $801,215 | -46.56% | 0.09% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 71,474 | $767,631 | 26.81% | 0.08% |
ALPS ADVISORS INC | 02/13/2025 | 68,566 | $736,399 | 7.17% | 0.08% |
SQUAREPOINT OPS LLC | 02/14/2025 | 67,627 | $726,314 | 304.88% | 0.08% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 66,810 | $717,540 | 5.10% | 0.08% |
Anavex Life Sciences Corp. institutional Ownership - FAQ's
During the previous two years, 197 institutional investors and hedge funds held shares of Anavex Life Sciences Corp.. The most heavily invested institutionals were:
BlackRock, Inc.: 6.55 M
VANGUARD GROUP INC: 4.68 M
STATE STREET CORP: 2.41 M
GEODE CAPITAL MANAGEMENT, LLC: 1.87 M
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 1.13 M
NWAM LLC: 913,051
34.83% of Anavex Life Sciences Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 37.61 M shares in the last 24 months. This purchase volume represents approximately $308.02 M in transactions.